Classification of traumatic brain injury for targeted therapies

Kathryn E. Saatman, Ann Christine Duhaime, Ross Bullock, Andrew I R Maas, Alex Valadka, Geoffrey T. Manley, David Brody, Charles Contant, Pramod Dash, Ramon Diaz-Arrastia, Stephanie Fertig, Alisa Gean, Clay Goodman, Wayne Gordon, Ronald Hayes, Ramona Hicks, Jean Langloi, Anthony Marmarou, David Moore, Gordon MurrayDavid Okonkwo, Linda Papa, Linda Phillips, Nikolaus Plesnila, Claudia Robertson, Courtney Robertson, Juan Sahuquillo, Robert Silbergleit, Ewout Steyerberg, Nino Stocchetti, Evelyn Teasdale, Graham Teasdale, Nancy Temkin, Hilaire Thompson, Karen Tong, Lindsay Wilson, David Wright

Research output: Contribution to journalArticle

587 Citations (Scopus)

Abstract

The heterogeneity of traumatic brain injury (TBI) is considered one of the most significant barriers to finding effective therapeutic interventions. In October, 2007, the National Institute of Neurological Disorders and Stroke, with support from the Brain Injury Association of America, the Defense and Veterans Brain Injury Center, and the National Institute of Disability and Rehabilitation Research, convened a workshop to outline the steps needed to develop a reliable, efficient and valid classification system for TBI that could be used to link specific patterns of brain and neurovascular injury with appropriate therapeutic interventions. Currently, the Glasgow Coma Scale (GCS) is the primary selection criterion for inclusion in most TBI clinical trials. While the GCS is extremely useful in the clinical management and prognosis of TBI, it does not provide specific information about the pathophysiologic mechanisms which are responsible for neurological deficits and targeted by interventions. On the premise that brain injuries with similar pathoanatomic features are likely to share common pathophysiologic mechanisms, participants proposed that a new, multidimensional classification system should be developed for TBI clinical trials. It was agreed that preclinical models were vital in establishing pathophysiologic mechanisms relevant to specific pathoanatomic types of TBI and verifying that a given therapeutic approach improves outcome in these targeted TBI types. In a clinical trial, patients with the targeted pathoanatomic injury type would be selected using an initial diagnostic entry criterion, including their severity of injury. Coexisting brain injury types would be identified and multivariate prognostic modeling used for refinement of inclusion/exclusion criteria and patient stratification. Outcome assessment would utilize endpoints relevant to the targeted injury type. Advantages and disadvantages of currently available diagnostic, monitoring, and assessment tools were discussed. Recommendations were made for enhancing the utility of available or emerging tools in order to facilitate implementation of a pathoanatomic classification approach for clinical trials.

Original languageEnglish
Pages (from-to)719-738
Number of pages20
JournalJournal of Neurotrauma
Volume25
Issue number7
DOIs
StatePublished - Jul 1 2008

Fingerprint

Brain Injuries
Clinical Trials
Glasgow Coma Scale
Therapeutics
Wounds and Injuries
National Institute of Neurological Disorders and Stroke
Veterans
Traumatic Brain Injury
Patient Selection
Outcome Assessment (Health Care)
Education

Keywords

  • Clinical trial
  • Head injury
  • Intervention
  • Outcome
  • Therapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Saatman, K. E., Duhaime, A. C., Bullock, R., Maas, A. I. R., Valadka, A., Manley, G. T., ... Wright, D. (2008). Classification of traumatic brain injury for targeted therapies. Journal of Neurotrauma, 25(7), 719-738. https://doi.org/10.1089/neu.2008.0586

Classification of traumatic brain injury for targeted therapies. / Saatman, Kathryn E.; Duhaime, Ann Christine; Bullock, Ross; Maas, Andrew I R; Valadka, Alex; Manley, Geoffrey T.; Brody, David; Contant, Charles; Dash, Pramod; Diaz-Arrastia, Ramon; Fertig, Stephanie; Gean, Alisa; Goodman, Clay; Gordon, Wayne; Hayes, Ronald; Hicks, Ramona; Langloi, Jean; Marmarou, Anthony; Moore, David; Murray, Gordon; Okonkwo, David; Papa, Linda; Phillips, Linda; Plesnila, Nikolaus; Robertson, Claudia; Robertson, Courtney; Sahuquillo, Juan; Silbergleit, Robert; Steyerberg, Ewout; Stocchetti, Nino; Teasdale, Evelyn; Teasdale, Graham; Temkin, Nancy; Thompson, Hilaire; Tong, Karen; Wilson, Lindsay; Wright, David.

In: Journal of Neurotrauma, Vol. 25, No. 7, 01.07.2008, p. 719-738.

Research output: Contribution to journalArticle

Saatman, KE, Duhaime, AC, Bullock, R, Maas, AIR, Valadka, A, Manley, GT, Brody, D, Contant, C, Dash, P, Diaz-Arrastia, R, Fertig, S, Gean, A, Goodman, C, Gordon, W, Hayes, R, Hicks, R, Langloi, J, Marmarou, A, Moore, D, Murray, G, Okonkwo, D, Papa, L, Phillips, L, Plesnila, N, Robertson, C, Robertson, C, Sahuquillo, J, Silbergleit, R, Steyerberg, E, Stocchetti, N, Teasdale, E, Teasdale, G, Temkin, N, Thompson, H, Tong, K, Wilson, L & Wright, D 2008, 'Classification of traumatic brain injury for targeted therapies', Journal of Neurotrauma, vol. 25, no. 7, pp. 719-738. https://doi.org/10.1089/neu.2008.0586
Saatman KE, Duhaime AC, Bullock R, Maas AIR, Valadka A, Manley GT et al. Classification of traumatic brain injury for targeted therapies. Journal of Neurotrauma. 2008 Jul 1;25(7):719-738. https://doi.org/10.1089/neu.2008.0586
Saatman, Kathryn E. ; Duhaime, Ann Christine ; Bullock, Ross ; Maas, Andrew I R ; Valadka, Alex ; Manley, Geoffrey T. ; Brody, David ; Contant, Charles ; Dash, Pramod ; Diaz-Arrastia, Ramon ; Fertig, Stephanie ; Gean, Alisa ; Goodman, Clay ; Gordon, Wayne ; Hayes, Ronald ; Hicks, Ramona ; Langloi, Jean ; Marmarou, Anthony ; Moore, David ; Murray, Gordon ; Okonkwo, David ; Papa, Linda ; Phillips, Linda ; Plesnila, Nikolaus ; Robertson, Claudia ; Robertson, Courtney ; Sahuquillo, Juan ; Silbergleit, Robert ; Steyerberg, Ewout ; Stocchetti, Nino ; Teasdale, Evelyn ; Teasdale, Graham ; Temkin, Nancy ; Thompson, Hilaire ; Tong, Karen ; Wilson, Lindsay ; Wright, David. / Classification of traumatic brain injury for targeted therapies. In: Journal of Neurotrauma. 2008 ; Vol. 25, No. 7. pp. 719-738.
@article{6082d29702f14c8b8534dfe4e1938443,
title = "Classification of traumatic brain injury for targeted therapies",
abstract = "The heterogeneity of traumatic brain injury (TBI) is considered one of the most significant barriers to finding effective therapeutic interventions. In October, 2007, the National Institute of Neurological Disorders and Stroke, with support from the Brain Injury Association of America, the Defense and Veterans Brain Injury Center, and the National Institute of Disability and Rehabilitation Research, convened a workshop to outline the steps needed to develop a reliable, efficient and valid classification system for TBI that could be used to link specific patterns of brain and neurovascular injury with appropriate therapeutic interventions. Currently, the Glasgow Coma Scale (GCS) is the primary selection criterion for inclusion in most TBI clinical trials. While the GCS is extremely useful in the clinical management and prognosis of TBI, it does not provide specific information about the pathophysiologic mechanisms which are responsible for neurological deficits and targeted by interventions. On the premise that brain injuries with similar pathoanatomic features are likely to share common pathophysiologic mechanisms, participants proposed that a new, multidimensional classification system should be developed for TBI clinical trials. It was agreed that preclinical models were vital in establishing pathophysiologic mechanisms relevant to specific pathoanatomic types of TBI and verifying that a given therapeutic approach improves outcome in these targeted TBI types. In a clinical trial, patients with the targeted pathoanatomic injury type would be selected using an initial diagnostic entry criterion, including their severity of injury. Coexisting brain injury types would be identified and multivariate prognostic modeling used for refinement of inclusion/exclusion criteria and patient stratification. Outcome assessment would utilize endpoints relevant to the targeted injury type. Advantages and disadvantages of currently available diagnostic, monitoring, and assessment tools were discussed. Recommendations were made for enhancing the utility of available or emerging tools in order to facilitate implementation of a pathoanatomic classification approach for clinical trials.",
keywords = "Clinical trial, Head injury, Intervention, Outcome, Therapy",
author = "Saatman, {Kathryn E.} and Duhaime, {Ann Christine} and Ross Bullock and Maas, {Andrew I R} and Alex Valadka and Manley, {Geoffrey T.} and David Brody and Charles Contant and Pramod Dash and Ramon Diaz-Arrastia and Stephanie Fertig and Alisa Gean and Clay Goodman and Wayne Gordon and Ronald Hayes and Ramona Hicks and Jean Langloi and Anthony Marmarou and David Moore and Gordon Murray and David Okonkwo and Linda Papa and Linda Phillips and Nikolaus Plesnila and Claudia Robertson and Courtney Robertson and Juan Sahuquillo and Robert Silbergleit and Ewout Steyerberg and Nino Stocchetti and Evelyn Teasdale and Graham Teasdale and Nancy Temkin and Hilaire Thompson and Karen Tong and Lindsay Wilson and David Wright",
year = "2008",
month = "7",
day = "1",
doi = "10.1089/neu.2008.0586",
language = "English",
volume = "25",
pages = "719--738",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

TY - JOUR

T1 - Classification of traumatic brain injury for targeted therapies

AU - Saatman, Kathryn E.

AU - Duhaime, Ann Christine

AU - Bullock, Ross

AU - Maas, Andrew I R

AU - Valadka, Alex

AU - Manley, Geoffrey T.

AU - Brody, David

AU - Contant, Charles

AU - Dash, Pramod

AU - Diaz-Arrastia, Ramon

AU - Fertig, Stephanie

AU - Gean, Alisa

AU - Goodman, Clay

AU - Gordon, Wayne

AU - Hayes, Ronald

AU - Hicks, Ramona

AU - Langloi, Jean

AU - Marmarou, Anthony

AU - Moore, David

AU - Murray, Gordon

AU - Okonkwo, David

AU - Papa, Linda

AU - Phillips, Linda

AU - Plesnila, Nikolaus

AU - Robertson, Claudia

AU - Robertson, Courtney

AU - Sahuquillo, Juan

AU - Silbergleit, Robert

AU - Steyerberg, Ewout

AU - Stocchetti, Nino

AU - Teasdale, Evelyn

AU - Teasdale, Graham

AU - Temkin, Nancy

AU - Thompson, Hilaire

AU - Tong, Karen

AU - Wilson, Lindsay

AU - Wright, David

PY - 2008/7/1

Y1 - 2008/7/1

N2 - The heterogeneity of traumatic brain injury (TBI) is considered one of the most significant barriers to finding effective therapeutic interventions. In October, 2007, the National Institute of Neurological Disorders and Stroke, with support from the Brain Injury Association of America, the Defense and Veterans Brain Injury Center, and the National Institute of Disability and Rehabilitation Research, convened a workshop to outline the steps needed to develop a reliable, efficient and valid classification system for TBI that could be used to link specific patterns of brain and neurovascular injury with appropriate therapeutic interventions. Currently, the Glasgow Coma Scale (GCS) is the primary selection criterion for inclusion in most TBI clinical trials. While the GCS is extremely useful in the clinical management and prognosis of TBI, it does not provide specific information about the pathophysiologic mechanisms which are responsible for neurological deficits and targeted by interventions. On the premise that brain injuries with similar pathoanatomic features are likely to share common pathophysiologic mechanisms, participants proposed that a new, multidimensional classification system should be developed for TBI clinical trials. It was agreed that preclinical models were vital in establishing pathophysiologic mechanisms relevant to specific pathoanatomic types of TBI and verifying that a given therapeutic approach improves outcome in these targeted TBI types. In a clinical trial, patients with the targeted pathoanatomic injury type would be selected using an initial diagnostic entry criterion, including their severity of injury. Coexisting brain injury types would be identified and multivariate prognostic modeling used for refinement of inclusion/exclusion criteria and patient stratification. Outcome assessment would utilize endpoints relevant to the targeted injury type. Advantages and disadvantages of currently available diagnostic, monitoring, and assessment tools were discussed. Recommendations were made for enhancing the utility of available or emerging tools in order to facilitate implementation of a pathoanatomic classification approach for clinical trials.

AB - The heterogeneity of traumatic brain injury (TBI) is considered one of the most significant barriers to finding effective therapeutic interventions. In October, 2007, the National Institute of Neurological Disorders and Stroke, with support from the Brain Injury Association of America, the Defense and Veterans Brain Injury Center, and the National Institute of Disability and Rehabilitation Research, convened a workshop to outline the steps needed to develop a reliable, efficient and valid classification system for TBI that could be used to link specific patterns of brain and neurovascular injury with appropriate therapeutic interventions. Currently, the Glasgow Coma Scale (GCS) is the primary selection criterion for inclusion in most TBI clinical trials. While the GCS is extremely useful in the clinical management and prognosis of TBI, it does not provide specific information about the pathophysiologic mechanisms which are responsible for neurological deficits and targeted by interventions. On the premise that brain injuries with similar pathoanatomic features are likely to share common pathophysiologic mechanisms, participants proposed that a new, multidimensional classification system should be developed for TBI clinical trials. It was agreed that preclinical models were vital in establishing pathophysiologic mechanisms relevant to specific pathoanatomic types of TBI and verifying that a given therapeutic approach improves outcome in these targeted TBI types. In a clinical trial, patients with the targeted pathoanatomic injury type would be selected using an initial diagnostic entry criterion, including their severity of injury. Coexisting brain injury types would be identified and multivariate prognostic modeling used for refinement of inclusion/exclusion criteria and patient stratification. Outcome assessment would utilize endpoints relevant to the targeted injury type. Advantages and disadvantages of currently available diagnostic, monitoring, and assessment tools were discussed. Recommendations were made for enhancing the utility of available or emerging tools in order to facilitate implementation of a pathoanatomic classification approach for clinical trials.

KW - Clinical trial

KW - Head injury

KW - Intervention

KW - Outcome

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=48249108682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249108682&partnerID=8YFLogxK

U2 - 10.1089/neu.2008.0586

DO - 10.1089/neu.2008.0586

M3 - Article

C2 - 18627252

AN - SCOPUS:48249108682

VL - 25

SP - 719

EP - 738

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 7

ER -